| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5566401 | American Journal of Infection Control | 2017 | 4 Pages |
Abstract
Patients with SAB receiving an IDC were more likely to receive guideline-congruent management and had significantly reduced mortality. No improvements in antibiotic choice or dosing were observed, likely a result of ASP review.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Kevin PharmD, Jennifer MD, Zhe PharmD, Natasha N. PharmD,